News

A letter was sent on behalf of the members of the Society for Research on Nicotine and Tobacco (SRNT), the American Association for Cancer Research (AACR), the College on Problems with Drug Depende

IASLC sends a letter to the American Red Cross asking them to stop accepting money from the tobacco industry.

January 2015 Newsletter

This year, the results from two large IASLC projects will be presented. The IASLC Staging Committee, under the leadership of Dr. Rami-Porta, will present the new staging system for lung cancer,

The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) are teaming to revise the evidence-based guideline, "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors."

The International Association for the Study of Lung Cancer (IASLC) education teams will travel to various geographical locations within their regions in order to teach others the importance of and how to implement molecular testing using small group interactive learning sessions and hands-on approaches. The educational team will consist of medical oncologists, surgeons, pulmonologists, interventional radiologists, pathologists, nurses, laboratory personnel, molecular biologists, cytogeneticists, bioinformaticists and other scientists.

December 2014 Newsletter

As we approach the end of the year, I am very proud to share with you that this year has been a very successful year for IASLC!
Our meetings, both regional meetings and smaller meetings/workshops, have been very successful in terms of science and attendance. For the next year we will have the World Conference in September; we will continue our more “traditional” smaller meetings; we will also expand the focused meetings, which will include an expert meeting on Small Cell Lung Cancer in April in New York City, and we will also plan for a specific immunotherapy meeting in the fall of 2015.

Pages